OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
1
Result
Show all
Save search
Copy query
Show results for
Proteomics
(1)
Organisms
Bacillus anthracis str. Ames
(1)
Vaccinia virus Western Reserve
(1)
Punica granatum
(1)
Dendrocalamus latiflorus
(1)
Abyssorchomene distinctus
(1)
Macrophomina phaseolina
(1)
Cellana toreuma
(1)
Megabalanus volcano
(1)
Candidatus Electronema
(1)
Sulfurimonas denitrificans
(1)
mixed DNA libraries
(1)
Streptococcus suis SC149
(1)
NEWT:86260
(1)
Bartonella grahamii
(1)
Trichomonas vaginalis
(1)
Pseudomonas aeruginosa PAO579
(1)
Perca fluviatilis
(1)
Blastobotrys
(1)
Agrostemma githago
(1)
Silene conica
(1)
Chrysoporthe cubensis
(1)
Semliki Forest virus
(1)
Brassica oleracea var. oleracea
(1)
Histoplasma capsulatum G186AR
(1)
Leeuwenhoekiella sp. MAR_2009_132
(1)
Mucuna sempervirens
(1)
Lolium perenne
(1)
Coxiella burnetii Dugway 5J108-111
(1)
Lolium perenne/Epichloe festucae mixed library
(1)
Severe acute respiratory syndrome-related coronavirus
(1)
Repository
pride
(1)
Tissue
Breast epithelium
(1)
Cell culture
(1)
Disease
Breast cancer
(1)
Technology Type
Mass Spectrometry
(1)
Shotgun proteomics
(1)
Publication Date
2021
(1)
Lab affiliation
Università degli studi della Campania Luigi Vanvitelli.
(1)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
IP-MS of LSD1 and ER in treated Breast cancer cells
These proteomic data were produced in order to assess the effect of drug 3324, a pan-lysine demethylase inhibitor, on the estrogen receptor (ER) and Lysine Demethylase1 (LSD1)protein interaction networks.
ORGANISM(S):
Homo sapiens (Human)
2021-09-08
|
PXD012781
|
Pride
Human
Breast cancer
Pulldown
Estrogen receptor
Lysisne deaminase
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets
